iLoF

iLoF is a digital health company developing an AI-powered platform that uses proprietary photonics technology to generate optical fingerprints from blood samples, building a cloud-based library of biological profiles and biomarkers.

The platform enables non-invasive patient stratification and personalised drug matching for clinical and preclinical trials, with an initial focus on Alzheimer's disease.

Backed by Microsoft Ventures and Hamamatsu Ventures, iLoF operates from its R&D base at Discovery Park in Kent.